| 000 | 01345 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514072913.0 | ||
| 264 | 0 | _c20030909 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a0890-9091 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKauh, John | |
| 245 | 0 | 0 |
_aMantle cell lymphoma: clinicopathologic features and treatments. _h[electronic resource] |
| 260 |
_bOncology (Williston Park, N.Y.) _cJun 2003 |
||
| 300 |
_a879-91, 896; discussion 896-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aChromosomes, Human, Pair 11 _xgenetics |
| 650 | 0 | 4 |
_aChromosomes, Human, Pair 14 _xgenetics |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 700 | 1 | _aBaidas, Said M | |
| 700 | 1 | _aOzdemirli, Metin | |
| 700 | 1 | _aCheson, Bruce D | |
| 773 | 0 |
_tOncology (Williston Park, N.Y.) _gvol. 17 _gno. 6 _gp. 879-91, 896; discussion 896-8 |
|
| 999 |
_c12627254 _d12627254 |
||